As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role ...

Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last ...

Wegovy is produced by pharmaceutical company Novo Nordisk. Weight-loss drug makers are directly targeting employers in a ...

(Reuters) - Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help ...

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health ...

Drugmakers are likewise reaching out to other employers with the message that treating obesity will ultimately save them money.

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...